Evaluating the efficacy and safety of SpikoGen®, an Advax-CpG55.2–adjuvanted severe acute respiratory syndrome coronavirus 2 spike protein vaccine: a phase 3 randomized placebo-controlled trial

Payam Tabarsi, Nassim Anjidani, Ramin Shahpari, Masoud Mardani, Araz Sabzvari, Babak Yazdani, Hamidreza Kafi, Newsha Fallah, Ali Ebrahimi, Ali Taheri, Nikolai Petrovsky, Saghar Barati

Research output: Contribution to journal › Article › peer-review

36 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Evaluating the efficacy and safety of SpikoGen®, an Advax-CpG55.2–adjuvanted severe acute respiratory syndrome coronavirus 2 spike protein vaccine: a phase 3 randomized placebo-controlled trial'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science